Epsilon M&A Deal Report - InGen BioSciences
Transaction Multiples for the Valuation of Private Companies
ExonHit / InGen BioSciences
No EMAT :
52397
Announced Date :
06/11/2012
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
ExonHit
Target :
InGen BioSciences
Country :
France
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Founded in 1993, InGen BioSciences develops, commercializes, and distributes diagnostic tests for use in medical biology laboratories. These diagnostic tests are distributed exclusively for One...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
|
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 26/11/2012 | Trivitron Healthcare Pvt | Ani Labsystems Group | Finland | * | 52295 |
| 10/10/2012 | Edwards Lifesciences | BMEYE | Netherlands | * | 52136 |
Source: Epsilon Research / EMAT
